Introduction {#s1}
============

In agricultural systems, reduced nitrogen is often limiting and thus requires application of nitrogen fertilizer, which has both cost and environmental concerns ([@CIT0019]). Most legume species develop a symbiotic relationship with soil rhizobia that reduces the need for this input due to biological nitrogen fixation. Rhizobia undergo differentiation to bacteroids and are housed in a complex organ, known as a nodule, which maintains the conditions required for nitrogen fixation to occur. The nodule develops on the roots through a re-initiation of cell divisions and concurrent infection events (reviewed by [@CIT0010]; [@CIT0008]).

The development of nodules is regulated by the plant in response to internal and external cues, including available reduced nitrogen, and through a systemic regulatory mechanism known as the autoregulation of nodulation (AON; first proposed by [@CIT0014]). AON is established in response to early nodulation signalling events through long-distance signals between the root and shoot ([@CIT0007]; [@CIT0029]; [@CIT0048]) and is maintained by the nodulation autoregulation receptor kinase (GmNARK) in soybean ([@CIT0053]). GmNARK is structurally similar to the CLAVATA1 (CLV1) receptor kinase of *Arabidopsis* ([@CIT0004]), and is functionally conserved with its homologues from other legume species ([@CIT0026]; [@CIT0041]; [@CIT0051]).

In *Arabidopsis*, the leucine-rich repeat-receptor kinase (LRR-RK) CLAVATA1 regulates the stem cell population of the shoot apical meristem (SAM) through direct perception of the small peptide CLV3 ([@CIT0013]; [@CIT0043]) in a negative feedback loop with the transcription factor WUSCHEL (WUS; [@CIT0002]; [@CIT0052]). Both the CLV3 peptide and WUS protein may act in cells at a distance from their origin of production via intercellular movement ([@CIT0028]; [@CIT0059]). Many similarities exist between the functional components of the CLV system and AON (reviewed in [@CIT0048]), including the recent identification of a *WUSCHEL-RELATED HOMEOBOX* gene (*WOX5*; [@CIT0046]), a *KINASE-ASSOCIATED PROTEIN PHOSPHATASE* gene (*KAPP1*; [@CIT0035]), CLAVATA2-receptor protein-controlled supernodulation ([@CIT0027]), and CLE (CLV3/ESR-related) peptides.

CLE peptides functioning in the *Arabidopsis* CLV system regulate the stem cell population of the SAM via CLV1, whereas those of AON regulate nodulation in a *Gm*NARK-dependent manner ([@CIT0015]; [@CIT0045]; [@CIT0037]; [@CIT0047]). In soybean, three such CLE peptides have been characterized ([@CIT0030]; [@CIT0047]). They are induced in response to either nitrate (*GmNIC1*) or early infection and nodule establishment events in the root zone susceptible to nodulation (*GmRIC1* and *GmRIC2*; [@CIT0016]). *GmRIC1* and *GmRIC2* inhibit nodulation in a systemic manner when constitutively overexpressed in chimeric plants, with *GmRIC1* achieving complete suppression of nodulation in wild-type plants. In contrast, *GmNIC1* appears to act locally (as expected for nitrate inhibition of nodulation; see [@CIT0003]) and only partially, but significantly, suppresses nodulation when overexpressed ([@CIT0047]). The nodulation suppression activity (NSA) of *Gm*RIC1/*Gm*RIC2 is epistatically suppressed in a *Gm*NARK-deficient plant ([@CIT0047]), suggesting that the peptide signals through the LRR-RK (reminiscent of the CLV3--CLV1 situation).

The systemic activity of these CLE peptides, and the shoot involvement through *Gm*NARK, suggests that they may act as long-distance signal ligands for *Gm*NARK in the shoot \[NB: similar NSA was detected for CLE overexpression in *Lotus japonicus* ([@CIT0045]) and *Medicago truncatula* ([@CIT0037])\]. Indeed, it is predicted that perception of *Gm*RIC1/*Gm*RIC2 by *Gm*NARK in the shoot leads to the production of a novel shoot-derived inhibitor (SDI) signal that is transported to the root where it inhibits further nodulation events ([@CIT0032], [@CIT0031]), thus completing the systemic loop of AON (reviewed in [@CIT0048]). Knock-down of the two related CLE genes in *M. truncatula* resulted in an increase in nodule numbers, further indicating their likely role in inducing AON ([@CIT0036]). Despite this evidence, efforts to detect CLE peptides in xylem sap samples or root tissues of *GmRIC1*-overexpressing plants have not identified CLE peptides to date ([@CIT0049]).

Genes encoding CLE peptides are widely distributed in plant species, including \>20 CLE peptide encoding genes in *Arabidopsis* and over at least 40 in soybean ([@CIT0005]; [@CIT0042]; [@CIT0038]). CLE peptides possess three basic domains, namely an N-terminal transit (signal) peptide, a variable region which does not share a high degree of homology within the family (beyond predicted hydrophobicity), and a 12--13 amino acid CLE domain ([@CIT0005]). Post-translational modifications and processing are required to produce the 12--13 amino acid mature CLE peptide ([@CIT0024]; [@CIT0044]). These modifications include proline hydroxylation and arabinosylation which have been detected for several CLE peptides \[CLV3 and CLE2 ([@CIT0044]), CLE9 ([@CIT0055])\]. Amino acid residues neighbouring the CLE domain have been proposed to be required for efficient processing of the mature peptide through proteolytic cleavage ([@CIT0039]; [@CIT0009]; [@CIT0040]). The transit peptide has been shown to be critical to the nodule inhibition and secretion of green fluorescent protein (GFP)-tagged *Gm*RIC1 and *Gm*RIC2 peptides ([@CIT0030]). In addition to the conserved CLE peptide domain, several of the rhizobia-induced CLE peptides in *L. japonicus*, *M. truncatula*, and *Glycine max*, as well as *At*CLV3, possess a conserved extension in the C-terminal region of the CLE pre-propeptide comprising dual proline residues. The functional significance of these residues is unclear, but they may assist in processing, protection from degradation, or binding of the CLE peptide.

A number of studies using *At*CLV3 have employed site-directed mutagenesis (SDM) constructs *in vivo* ([@CIT0040]; [@CIT0056]), and *in vitro* peptide application ([@CIT0023]), or domain swap techniques ([@CIT0034]), to decipher the role of each of the domains of the CLE pre-propeptides. Alanine replacement mutants at each of the residues within the *At*CLV3 domain and surrounding residues have shown that mutants at the R1, P4, G6, D8, P9, L10, H11, and H12 residues of the *At*CLV3 peptide were significantly compromised in their ability to complement *Atclv3* mutants ([@CIT0056]). Synthetic CLE peptides consisting solely of the CLE domain residues, and engineered genes encoding the transit peptide directly adjacent to the CLE domain, have also been shown to be biologically active and effective at rescuing some *Atclv3* phenotypes ([@CIT0012], [@CIT0011]). In addition to the importance of the CLE domain, the R70 residue of *At*CLV3, which immediately precedes the CLE domain, has been identified as a peptilytic processing site; however, mutants at this residue continue to maintain activity ([@CIT0039]). Up to four residues may be required for cleavage recognition and processing at this residue in the N-terminus of the CLE peptide. A serine protease is likely to be the precise cleaving agent at this location, whereas a progressive carboxypeptidase acts at the C-terminus ([@CIT0040]). Mutations at the EE residues preceding the *At*CLV3 peptide domain blocked processing but continued to rescue mutant phenotypes, which may indicate that the processing is not required to be highly efficient due to high specificity and very low concentrations of the peptide required for activity. It has been shown that the CLE domain and transit peptide determines the function and specificity of the peptide ([@CIT0011]; [@CIT0034]), probably through determining to which tissues and receptors the ligand is presented. This tissue specificity is also a result of the diverse expression patterns that exist for the CLE-encoding genes ([@CIT0054]; [@CIT0020]).

The *Gm*RIC1 CLE domain shares high sequence similarity with the *Arabidopsis* CLE1--CLE7 peptides, with the consensus sequence only varying at the final residue (H in the *Arabidopsis* CLE1--CLE7 peptides compared with N in the nodulation CLE peptides). The function of these *Arabidopsis* CLE peptides remains to be determined; they do not possess the common root apical meristem (RAM)-arresting phenotypes of other CLE peptides and do not induce significant changes in SAM size when applied directly to the plant ([@CIT0022]). It should be noted that direct plant application may lessen activity because of degradation and possible uptake barriers. Overexpression of genes encoding *At*CLE1--*At*CLE7 peptides does, however, indicate that they possess biological activity as it results in phenotypes similar to *AtCLV3* overexpression, albeit with less severe phenotypes ([@CIT0057]). Key residues within *Gm*RIC1 are conserved throughout CLE peptides, including an almost universal conservation of the residues indicated in bold on the *Gm*RIC1 sequence: **R**LA**P**E**GP***D* **P**H**H***N* (italics indicate one of two possible amino acids; [@CIT0042]).

The complete suppression phenotype obtained in *GmRIC1*-overexpressing roots of soybean ([@CIT0047]) provides an excellent system to investigate the contribution of key residues within the CLE peptide to its overall function. To investigate the relative importance of each residue in the CLE domain to the function of *Gm*RIC1, an SDM study was initiated. In addition, chimeric constructs comprised of swapped functional domains of *Gm*RIC1 and *Gm*NIC1 were generated to identify which domains contribute to nodule suppression activity and which are critical for localization of the peptide. These experiments allowed the identification of the key residues required for nodule suppression in soybean and will assist in the identification of biologically active CLE peptides capable of nodule suppression in other legume species. These experiments also provide a basis to compare the function of individual residues within nodulation-suppressing CLE peptides with those identified as critical in different species and developmental processes such as obtained from the study of *At*CLV3.

Materials and methods {#s2}
=====================

General plant and bacterial growth conditions and the nodulation assay {#s3}
----------------------------------------------------------------------

Soybean (*Glycine max* L. Merrill) wild-type Bragg plants were grown in controlled glasshouse conditions (28 °C/26 °C day/night) in 4 litre pots containing grade 3 vermiculite. Plants were watered as required with a modified nutrient solution lacking nitrogen ([@CIT0018]). Plants were inoculated with \~200ml of *Bradyrhizobium japonicum* CB1809 grown in yeast-mannitol broth (YMB) at 28 °C for 4 d and diluted to \~OD~600~ 0.01. Nodulation was scored 3 weeks after inoculation. Student's *t*-tests were used to determine statistical differences.

Generating constructs and transgenic soybean roots {#s4}
--------------------------------------------------

Constructs bearing the coding sequence of *GmRIC1* and *GmNIC1* cloned in the sense direction only of the pKANNIBAL vector for expression of RNA interference (RNAi) constructs were used as described previously ([@CIT0058]; [@CIT0047]). *Pfu* polymerase (Stratagene, La Jolla, CA, USA) was used to amplify PCR products incorporating restriction nuclease sites from these constructs. *Xho*I/*Eco*RI (for) and *KpnI* (rev) restriction sites were included in the primer sequences depending on internal restriction sites of each gene (full primer sequences are included in [Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert008/-/DC1) available at *JXB* online). Likely clones were confirmed by direct DNA sequencing and capillary separation. Constructs were subcloned into p15SRK2 integration vectors (A. Kereszt, unpublished) as a *Not*I fragment before tri-parental mating to introduce them into *Agrobacterium rhizogenes* K599. *Agrobacterium rhizogenes* was subsequently used for the induction of transgenic soybean hairy roots according to [@CIT0021] and [@CIT0031].

Site-directed mutagenesis and domain swaps {#s5}
------------------------------------------

Point mutants of *GmRIC1* were introduced into the cloning vector pKANNIBAL:*GmRIC1* using PCR-based SDM. The forward and reverse oligonucleotide primers ([Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert008/-/DC1) at *JXB* online) were complementary to the opposite strands of the vector, and contained the desired mutation in the middle of the primers. Extension with these primers generated mutated plasmids at the relevant sites. Each PCR had a total volume of 25 μl containing 5 μl of 5× KAPA HiFi Buffer, 0.75 μl of 10mM dNTPs, 1 μl of each primer (10 μM), 0.25 μl of 25mM MgCl~2~, 0.5 μl of KAPA HiFi Polymerase (KAPA biosystems, cat. kk2101), and 6ng of pKANNIBAL:*GmRIC1* DNA. The reaction program was as follows: one cycle of initial denaturation (95 °C for 3min 30 s), three cycles of amplification with a lower annealing temperature (95 °C for 20 s, 60 °C for 15 s, 72 °C for 3min 30 s), 19 cycles of amplification with a high annealing temperature (65 °C), and one cycle of extension (72 °C for 10min), before the reaction was cooled to 4 °C. The PCR products were treated with the methylation-sensitive endonuclease *Dpn*I (NEB, Ipswich, MA, USA) for 1h at 37 °C to digest the parental DNA template and select for mutation-containing plasmids. The resulting undigested plasmids were used to transform competent TOP10 cells. All constructs were confirmed by direct DNA sequencing.

Chimeric gene domain swaps between regions of *GmRIC1* and *GmNIC1* were derived from pKANNIBAL:*GmRIC1* and pKANNIBAL:*GmNIC1*. This required using either a long reverse primer method for modifications directly at the C-terminus ([@CIT0034]) or the generation of overlapping PCR products before amplification with the outermost forward and reverse primers ([@CIT0017]). Primer sequences are shown in [Supplementary Table S2](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert008/-/DC1) at *JXB* online. For the purpose of constructing chimeric genes, the transit peptide was identified through SignalP prediction of the most likely cleavage sites ([@CIT0001]) and comprises residues 1--29 for *Gm*RIC1 and 1--30 for *Gm*NIC1. The variable region comprises the central residues from 30 to 76 inclusive in *Gm*RIC1 and 31 to 75 in *Gm*NIC1, while the CLE domain comprised the 12 amino acids from 77 to 88 in *Gm*RIC1 and 76 to 87 in *Gm*NIC1. The residues 89--95 in the C-terminal region of *Gm*RIC1 were defined as the C-terminal extension.

Results {#s6}
=======

Identification of critical GmRIC1 residues for nodule inhibition {#s7}
----------------------------------------------------------------

To investigate the functional importance of the amino acids within the CLE domain of *Gm*RIC1, point mutations were produced for each residue ([Fig. 1A](#F1){ref-type="fig"}). The *Gm*RIC1 CLE domain is comprised of 12 amino acids positioned from R77 to N88 in the *Gm*RIC1 sequence, which corresponds to R1--N12 in the CLE domain. Alanine substitutions were created at the L2, E5, G6, P7, D8, P9, H10, H11, and N12 residues, and additional substitutions were also made at R1E, A3D, and P4R. All mutants were derived from a *GmRIC1* overexpression construct previously shown to inhibit soybean nodulation completely in a systemic and *Gm*NARK-dependent manner ([@CIT0047]).

![Constructs used in the nodule suppression assay. (A) Site-directed mutants derived from *Gm*RIC1 were created for each residue in the CLE domain as well as several well-conserved residues outside the CLE domain. (B) Chimeric gene constructs were derived from combinations of the *Gm*RIC1 and *Gm*NIC1 signal peptide, variable region, CLE domain, and C-terminal extension. Each construct was named according to the source of each domain (e.g. RRRR for *Gm*RIC1) and was expressed under the 35S promoter in *Agrobacterium rhizogenes*-induced hairy roots. (This figure is available in colour at *JXB* online.)](exbotj_ert008_f0001){#F1}

The nodule suppression activity of each construct was determined by comparing nodule numbers on *A. rhizogenes*-induced hairy roots of the empty vector (114 nodules ±10, *n*=12 in one representative experiment of four), with *GmRIC1* overexpression constructs showing 100% suppression of nodulation (0 nodules ±0, *n*=12 in each of four replicates). Constructs bearing A substitutions at L2, E5, P9, and H10 retained complete nodule suppression activity, while the A3D mutant showed only a slight disruption in suppression (93% suppression of nodulation, *P* \< 0.05 using Students *t*-test; [Fig. 2](#F2){ref-type="fig"}). R1E (72%), E5R (69%), G6A (52%), H11A (41%), and P7A (40%) all showed an intermediate loss of suppression, while the most severe loss of suppression was observed in N12A (21%), P4R (29%), and D8A (18%) when compared with RIC1 (*P* \< 0.05).

![Nodulation suppression activity (NSA) in *Gm*RIC1 site-directed mutants. Suppression of nodulation obtained by overexpression of each of the site-directed mutants was determined relative to the nodule number on empty vector-transformed controls. *Gm*RIC1 and mutants that do not disrupt *Gm*RIC1 function exhibit complete suppression.](exbotj_ert008_f0002){#F2}

Generation of multiple variants at conserved residues to investigate the effect of amino acid charge and size on GmRIC1 function {#s8}
--------------------------------------------------------------------------------------------------------------------------------

To determine the effect of amino acid charge and size on the function of the *Gm*RIC1 peptide, multiple substitutions were produced at two conserved residues in the CLE domain, L2 and E5 ([Fig. 3](#F3){ref-type="fig"}). A, N, and R mutants were created at L2, while A, T, V, and R mutants were created at E5 ([Figs 1A](#F1){ref-type="fig"}, [3](#F1){ref-type="fig"}). Each of the three mutations at L2, and A, T, and V mutations at E5 maintained 100% suppression of nodulation. In contrast, the E5R substitution resulted in 69% suppression of nodulation (*P* \< 0.05, [Fig. 2](#F2){ref-type="fig"}).

![Site-directed mutants of *Gm*RIC1 to determine effects of charge and size of amino acid substitutions. Multiple mutations were produced at two well-conserved residues within the CLE domain, L2 and E5. A, R, and N residues were substituted for L2, while A, R, T, and V were substituted for E5. The shaded R residue represents the only mutation that disrupted the complete suppression of nodulation.](exbotj_ert008_f0003){#F3}

Mutation of residues outside the GmRIC1 CLE domain to determine their role in nodule inhibition {#s9}
-----------------------------------------------------------------------------------------------

Certain residues located outside of the CLE domain are thought to be critical for the production of the mature peptide, including the signal peptide, the C-terminal region, and potential cleavage sites within the variable domain ([@CIT0011]; [@CIT0039]; [@CIT0009]; [@CIT0040]). Mutations were produced at several of these well-conserved residues to determine their effect on *Gm*RIC1 activity. Alanine substitutions were made at both the L31 and K58 residues of *Gm*RIC1. L31 is located adjacent to the C-terminus of the signal peptide and shares 100% identity across the known nodulation CLE peptides of *L. japonicus*, *M. truncatula*, and *G. max*. K58 is the best conserved residue in the variable region of the nodulation CLE peptides (70% identity between known nodulation CLE peptides). Neither substitution resulted in a reduction in suppression activity of *Gm*RIC1 ([Fig. 2](#F2){ref-type="fig"}).

Alanine substitutions were also produced at two locations in the C-terminal region of *Gm*RIC1, including the residue immediately adjacent to the predicted mature peptide (F89A), and two conserved P residues (92/93, a single construct bearing an AA substitution), which are conserved between 70% of nodulation-related CLE peptides. These substitutions also maintained complete nodule suppression activity.

Amino acid conservation in CLE peptides in relation to functional importance {#s10}
----------------------------------------------------------------------------

To determine whether amino acid conservation is a good indicator of functional importance, the results were compared with multiple sequence alignments of all CLE peptides reported to possess nodule suppression activity ([@CIT0047]) and with recent *At*CLV3 experiments involving site-directed mutagenesis ([@CIT0056]). Within the nodulation-related CLE peptides ([Fig. 4](#F4){ref-type="fig"}), R1, P4, G6, P7, and H11 residues show complete conservation and were all critical to activity in the present study. Additionally, the D8 and N12 residues are conserved in six out of seven nodulation-suppressing CLE peptides and showed reduced suppression activity when mutated. The E5 residue of *Gm*RIC1 differs from the consensus (G in 5/7) in other nodulation CLE peptides and did not alter activity when mutated to A, T, or V, but was compromised by a mutation to R (E81R). Similarly, the *Gm*RIC1 A3 residue differed from the consensus sequence at that position (S in 5/7) and had only a small effect on suppressive activity when mutated. The *Gm*RIC1 L2 residue is completely conserved between the nodulation-suppressing CLE peptides; however, three mutations to A, N, or R indicated that it was not critical to suppression. Neither P9, which is conserved in 70% of nodulation CLE peptides, nor H10, which differs from the consensus (Q in 4/7), was found to alter *Gm*RIC1 activity. None of the alanine mutations in conserved residues outside of the CLE domain, which included L31 (100% conserved), K58 (5/7), and PP92/93 (5/7), was shown to alter activity.

![Amino acid conservation and importance to GmRIC1 activity. Consensus sequence and level of conservation of each residue in the CLE peptides known to inhibit nodulation are indicated by LOGO alignment ([@CIT0006]). Relative conservation of the mutated GmRIC1 residues with reduced (blue) or wild-type (red) nodule suppression activity is shown. The blue E residue represents the activity of the E5R mutation, which most significantly altered activity.](exbotj_ert008_f0004){#F4}

Comparison of *Gm*RIC1 with *At*CLV3 showed that seven out of 12 residues in the CLE domain are common between them (see [Table 1](#T1){ref-type="table"}). Two of these seven conserved residues (P7 and P9) did not share functional importance between the present results and those of [@CIT0056]. The P7 residue was critical to *Gm*RIC1 but not to *At*CLV3 activity, whereas the opposite was true at P9, which was critical to *At*CLV3 but not to *Gm*RIC1. One of the four non-conserved residues (CLV3-H12/RIC1-N12) was critical to the function of both *Atclv3* complementation and legume suppression of nodulation.

###### 

*Comparison of critical residues in* Gm*RIC1 and* At*CLV3 as determined by site-directed mutagenesis by* [@CIT0056]

  ---------------------------------------------------------------------------- -- --- -- --- -- ---- -- --- -- ------ -- --- -- ---- -- --- -- --- -- ---- -- --- -- ---
  *Gm*RIC1 peptide                                                                R      L      A       P      E         G      P       D      P      H       H      N
  *At*CLV3 peptide                                                                R      T      V       P      S         G      P       D      P      L       H      H
  Residue required for *Gm*RIC1 nodule suppression                                Y      N      \*      Y      \*\*      Y      Y       Y      N      N       Y      Y
  Residue required for complementation of *clv3* fifth whorl ovary phenotype      Y      N      N       Y      N         Y      \*      Y      Y      \*      Y      Y
  ---------------------------------------------------------------------------- -- --- -- --- -- ---- -- --- -- ------ -- --- -- ---- -- --- -- --- -- ---- -- --- -- ---

\*Minor change; \*\*only for E\>R change.

Contribution of functional domains to GmRIC1 and GmNIC1 activity {#s11}
----------------------------------------------------------------

In contrast to *GmRIC1* overexpression, which results in 100% suppression of soybean nodulation, overexpression of *GmNIC1* only results in an \~50% reduction in nodule numbers ([@CIT0047]). To determine which domains contribute to this difference in suppression, several constructs were produced encoding chimeric versions of these two peptides ([Fig. 1B](#F1){ref-type="fig"}). The domains investigated included the transit peptide, variable region, CLE domain, and C-terminal extension. The constructs were named according to the source of their domain. For example, an unmodified *Gm*RIC1 construct was named RRRR, whereas a construct bearing the *Gm*RIC1 signal peptide, *Gm*NIC1 variable region, and CLE domain, and lacking the C-terminal extension, was named RNN, noting that the native *Gm*NIC1 peptide lacks the C-terminal extension domain ([Fig. 1B](#F1){ref-type="fig"}).

Analysis of the role of the signal peptide domain in GmRIC1 and GmNIC1 activity {#s12}
-------------------------------------------------------------------------------

As the signal peptide has been shown to control *Gm*RIC1 secretion ([@CIT0030]), experiments were conducted to determine whether the *Gm*NIC1 signal peptide was functionally interchangeable with *Gm*RIC1. A *Gm*RIC1 construct was produced where the *Gm*NIC1 signal peptide replaced the native signal peptide (NRRR). The equivalent *Gm*NIC1 construct bearing the native *Gm*RIC1 signal peptide (RNN) was also produced. The RNN construct resulted in significantly increased suppression of nodulation relative to *Gm*NIC1 (*P* \< 0.001; [Fig. 5](#F5){ref-type="fig"}). In contrast, the NRRR construct showed a significantly lower level of suppression relative to the complete suppression by the *Gm*RIC1 peptide (24% suppression, *P* \< 0.001).

![Suppression of nodulation by chimeric *Gm*NIC1 and *Gm*RIC1 constructs. Chimeric gene constructs were compared with the suppression of nodulation obtained by *Gm*RIC1 and *Gm*NIC1 overexpression. Genes were named according to the source of the transit peptide, variable region, CLE domain, and C-terminal extension, respectively (*Gm*RIC1 would be named RRRR, while *Gm*NIC1 is NNN as it lacks the C-terminal extension).](exbotj_ert008_f0005){#F5}

Analysis of the role of the C-terminal extension domain in GmRIC1 and GmNIC1 activity {#s13}
-------------------------------------------------------------------------------------

*GmRIC1* encodes a C-terminal extension after the CLE peptide domain which is conserved in 70% of nodulation-related CLE peptides as well as in *At*CLV3, but is absent in *Gm*NIC1. To determine if this domain plays a critical role in nodule suppression activity, both a *Gm*RIC1 construct where this domain was deleted (RRR) and a *Gm*NIC1 construct where the C-terminal domain of *Gm*RIC1 was added (NNNR) were produced. The function of *Gm*RIC1 was not altered by the deletion of the C-terminal extension (RRR) as complete nodule suppression was maintained ([Fig. 5](#F5){ref-type="fig"}). In contrast, the addition of the *Gm*RIC1 C-terminal extension to *Gm*NIC1 (NNNR) resulted in a significant increase in the suppression of nodulation (90% suppression, *P* \< 0.001).

Analysis of the role of the CLE peptide domain in GmRIC1 and GmNIC1 activity {#s14}
----------------------------------------------------------------------------

Constructs were created that swapped the CLE domains of *Gm*RIC1 and *Gm*NIC1 (RRNR and NNR) to determine their contribution to the suppression of nodulation. Constructs that swapped the CLE domain regions in the context of the C-terminal region of the donor peptide \[the C-terminal extension of *Gm*RIC1 (NNRR) or the stop codon for *Gm*NIC1 (RRN)\] were also produced. The *Gm*NIC1 peptide bearing the *Gm*RIC1 CLE domain (NNR) showed no significant change in activity relative to the native *Gm*NIC1 peptide (*P*=0.11; [Fig. 5](#F5){ref-type="fig"}). Similarly, the construct comprising the *Gm*NIC1 transit peptide and variable region together with *Gm*RIC1 CLE domain in native context adjacent to the *Gm*RIC1 C-terminal extension (NNRR) did not significantly alter suppression activity from that of *Gm*NIC1. Reciprocal swaps, where *Gm*RIC1 contained the G*m*NIC1 CLE domain (RRNR), showed significantly reduced nodule suppression activity relative to *Gm*RIC1 (*P* \< 0.001; [Fig. 5](#F5){ref-type="fig"}). Likewise, the *Gm*RIC-based construct carrying the CLE domain of *Gm*NIC1 but lacking a C-terminal extension (RRN) showed a significant reduction in suppression activity relative to both native *Gm*RIC1 and the *Gm*RIC1 construct lacking the C-terminal extension (RRR) (*P* \< 0.001; [Fig. 5](#F5){ref-type="fig"}).

Analysis of the role of the variable region domain in GmRIC1 and GmNIC1 activity {#s15}
--------------------------------------------------------------------------------

The central variable region of CLE peptides is not highly conserved amongst the nodulation-related CLE peptides and has not been unequivocally shown to exert functional specificity in previous CLE domain studies ([@CIT0039]; [@CIT0034]). Accordingly, specific constructs with direct swaps of this region were not produced. However, to determine any contribution of the variable region to differences in suppression activity, combinations of the constructs that varied only in this region (NNRR versus NRRR and RRN versus RNN) were compared. No significant difference in suppression activity was observed between the two alternative variable domains in the constructs with *Gm*NIC1 transit peptide and the *Gm*RIC1 CLE domain (NNRR versus NRRR; *P*=0.16; [Fig. 5](#F5){ref-type="fig"}). In contrast, the *Gm*NIC1 variable region enhanced suppression activity when a *Gm*RIC1 transit peptide and *Gm*NIC1 CLE domain were present adjacent to the variable region (RNN versus RRN; *P* \< 0.005; [Fig. 5](#F5){ref-type="fig"}).

Discussion {#s16}
==========

Although *Gm*NARK and *At*CLV1 are closely related homologues with high sequence similarity, little is known about their ligand specificity. The functional importance of the domains and many individual amino acids within *At*CLV3 has been well studied and provides an excellent basis to identify functional divergence from *Gm*RIC1 ([@CIT0023]; [@CIT0040]; [@CIT0056]). The experimental system used here, which was employed to identify critical residues within the *Gm*RIC1 peptide through assessment of nodule inhibition, provided a specific and easy to quantify assay having a large and dynamic range of detectable nodule numbers (0 in *GmRIC1* compared with an average of 114 nodules in controls). In addition, the chimeric *GmRIC1*-overexpressing plants do not show any secondary root or shoot developmental phenotypes outside of nodulation. This is not the case for all nodulation-related CLE peptides, as the application or expression of *Mt*CLE12 inhibits root growth in addition to nodulation ([@CIT0050]). These differences make the use of *Gm*RIC1 in the present assay ideal for analysing the function of CLE peptides in suppressing nodulation.

It was found that the R1, P4, G6, P7, D8, H11, and N12 residues within the *Gm*RIC1 CLE domain were most important to nodule suppression activity. In contrast, mutation of the A3 residue provided only a small disruption of suppression, while mutations in the L2, P9, and H10 residues did not alter activity, suggesting that they play a relatively minor role. The E5 residue was only disrupted by mutation to R, while A, T, and V mutants at E5 were unaffected in nodule suppression activity. Outside of the CLE domain, none of the individual residues tested was found to be critical; however, the *Gm*RIC1 signal peptide, CLE domain, and C-terminal extension region were all found to enhance the activity of *Gm*NIC1.

*At*CLV3 and *Gm*RIC1 CLE domain sequences are well conserved, including perfect conservation at seven out of 12 residues. Complementation of *Atclv3* plants with alanine substitution mutants showed that the R1, P4, G6, D8, P9, L10, H11, and H12 residues within the CLE domain were all critical to obtaining full complementation, whereas T2, V3, S5, and P7 mutants showed no alteration in activity ([@CIT0056]). Interestingly, the P7 residue which has been identified as a site of post-translational modification ([@CIT0044]) was not critical to function. Of the four residues which were identified as unimportant in *At*CLV3, three showed either no or only small loss of suppression activity in the present experiments and none of these was conserved (L2, A3, and E5). The fourth residue found to be unimportant in *At*CLV3, P7, was shown to be critical to activity in the present study. The structural effects of these changes and why they show increased tolerance of mutation remains unknown at this stage, but may be further clarified through determination of receptor--ligand structures and binding studies.

Interestingly, the *Gm*RIC1 P9 residue was not identified as important in the present study, despite being critical to *At*CLV3 activity ([@CIT0025]; [@CIT0056]). Indeed, using peptoid replacement of proline residues, [@CIT0025] showed that substitution could alter activity without altering binding. This difference may indicate an alteration of the post-translational modification site between *Gm*RIC1 and *At*CLV3, or a selective preference in the LRR receptor. The *Gm*RIC1 N12/*At*CLV3 H12 residue was shown to be critical to both peptides despite the lack of conservation (although both fall into the same charge class). It should be noted that both H and N residues are common at the C-terminus of CLE peptides ([@CIT0042]). The identification of D8 as a critical residue also confirms the finding by [@CIT0056] of the importance of this residue despite it being identified through *in vitro* application studies as lacking functional importance ([@CIT0023]). In contrast to this, the present finding that the H10 residue of *Gm*RIC1 did not alter activity was different from the minor role identified through *in vivo* complementation studies using *Atclv3* mutants ([@CIT0056]), but was consistent with a lack of activity observed at this position from *in vitro* peptide application studies ([@CIT0023]).

Whether differences in amino acid residue charge and size could affect *Gm*RIC1 activity at two residues that were initially identified as showing no effect when substituted with alanine (L2 and E5) was investigated. Loss of function by the E5R mutation suggests that the chemical properties of this amino acid do play a role, as only this acidic to basic change altered the suppression activity. This indicates that selection at these residues remains important, albeit with a greater tolerance to changes. It is possible that many of the residues determined to be unimportant are indeed critical to activity simply due to their role in establishing the peptide backbone.

Despite high levels of conservation at several amino acids located outside of the CLE domain, none showed a loss of activity in our study using *Gm*RIC1. This is consistent with previous studies ([@CIT0040]; [@CIT0056]) that failed to identify residues critical to activity outside of the CLE domain, despite several being identified as likely protease cleavage sites. This may indicate that a consensus sequence or motif is sufficient to target protease cleavage, or that sequence within the CLE peptide domain itself directs cleavage of surrounding residues.

Irrespective of the lack of critical residues identified outside of the CLE domain, the domain swap results provided significant evidence for the importance of these domains to the activity of nodulation-related CLE peptides. The importance of the *Gm*RIC1 transit peptide was confirmed to confer a significant functional advantage over the equivalent sequence from *Gm*NIC1. This is consistent with previous results identifying the transit peptide as important for the secretion of *Gm*RIC1 ([@CIT0030]). Several conserved residues within the transit peptide of nodulation-related peptides of soybean, *L. japonicus*, and *M. truncatula* were identified as altered in *Gm*NIC1 ([@CIT0047]) and it seems possible that some of these residues could play a role in the localization of the peptide.

Like the transit peptide domain, the CLE domain of *Gm*RIC1 was functionally superior relative to that of *Gm*NIC1. *Gm*NIC1 is the only nodulation-related CLE peptide with a H residue at position 12, where all others possess N12. Our studies demonstrated that N12 is critical to *Gm*RIC1 suppression of nodulation. Interestingly, *Gm*NIC1 is also one of only two identified nodulation-related CLE peptides lacking P9, despite alanine substitutions at this residue maintaining complete activity in the present study. Despite the conservation of two proline residues within the C-terminal tail region of *Gm*RIC1 and other nodulation-related CLE peptides, no functional importance could be determined for the region in *Gm*RIC1 as constructs with the domain deleted retained full activity. Interestingly, however, the domain did confer some advantage to *Gm*NIC1 when it was added. This suggests that the domain possibly enhances processing or protects the mature CLE from breakdown but is not essential to binding. The unchanged activity of the *Gm*RIC1 constructs may suggest that overexpression of *Gm*RIC1 generates a large enough pool of the mature peptide such that protection from cleavage is less important, or can be overcome by saturation of proteases with the peptide. In *Gm*NIC1, reduced breakdown of the mature peptide owing to the C-terminal extension in the NNNR construct may increases the lifetime and therefore the activity of the resulting peptide.

The least conserved region within CLE peptides is the region between the signal peptide and the CLE domain, termed the variable domain. The present results showed that neither the *Gm*RIC1 nor *Gm*NIC1 variable regions conferred a consistent advantage over the other. Of the two comparisons which were made, the *Gm*NIC1 variable region did increase suppression in one case, although it did not restore the activity to control levels and a comparable change was not observed in the reciprocal construct. This probably indicates that some advantage is conferred by different variable regions, especially if a specific protease is involved in cleavage, but that processing is likely to be by a less specific protease or is directed by neighbouring domains.

Taken together, the domain-swap results indicate a significant advantage of the *Gm*RIC1 transit peptide, CLE domain, and, to a lesser extent, the C-terminal tail region, over the corresponding domains in *Gm*NIC1. Although *Gm*NIC1 does inhibit nodulation in a *Gm*NARK-dependent manner, the low efficiency of this suppression may indicate that it is not the only CLE domain peptide in soybean that responds to nitrate, or that other mechanisms that are not dependent on CLE peptide--NARK signalling are more significant players. The data obtained in these studies may provide valuable assistance in identifying possible additional nitrate-responsive CLE peptides with increased nodule suppression efficiency. The low efficiency of *Gm*NIC1 may also indicate that *Gm*NIC1 has a secondary function in another nitrate-dependent signalling pathway via an alternative receptor. The lack of secondary phenotypes resulting in *Gm*NIC1-overexpressing plants, however, indicates that the developmental changes are subtle or are in some way altered in *Agrobacterium*-induced hairy root systems.

As one of only a few studies to investigate CLE peptide function outside of *Arabidopsis* and rice, the present results provide useful insight into the functional importance of the protein domains and many individual amino acids of this group of peptides. For example, the critical importance of the *Gm*RIC1 transit peptide identified here may provide a basis for further analysis of this domain to determine key residues for its activity. By identifying the tolerance to mutation at each of the residues of the RIC1 CLE domain and identifying the residues which are critical only in nodulation and not SAM regulation, the findings also provide useful insight into the evolution of CLE peptide signalling in plant development. The results may assist in the identification of CLE peptides in other legumes, particularly those that are likely to possess nodule inhibitory activity. Indeed, the highly sensitive and robust nodule suppression assay used here provides an excellent tool for future nodule suppression studies.
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Supplementary data are available at *JXB* online.

[Table S1.](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert008/-/DC1) Primer sequences for site-directed mutagenesis.

[Table S2.](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert008/-/DC1) Primers for domain swap constructs.
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